http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019210223-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99fb7a8548eb34c4b239e90588263814 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G59-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C39-17 |
| filingDate | 2018-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e981f1cf36973dcc45b8ff797a51e6af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_691a2a827c05c8440d6a8cfdf0d1dd02 |
| publicationDate | 2019-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2019210223-A |
| titleOfInvention | Curable composition and cured product thereof |
| abstract | The present invention provides a novel clathrate compound using a compound having an adamantane skeleton as a host. A guest compound having a host compound represented by the formula (1) and a 5- or 6-membered heterocyclic ring containing a plurality of nitrogen atoms as ring constituent atoms or a condensed heterocyclic ring thereof (for example, 2-ethyl-4 -Methyl imidazole, 2-methyl imidazole, 5-diazabicyclo [4.3.0] non-5-ene and the like). (Z is an arene ring, R 1 and R 2 are substituents, k is an integer of 1 or more, m is an integer of 0 or more, and n is an integer of 0 to 14) [Selection figure] None |
| priorityDate | 2018-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 477.